Company Filing History:
Years Active: 2007-2008
Title: The Innovative Contributions of Ming-Qiang Zhang
Introduction
Ming-Qiang Zhang is a notable inventor based in Cherry Hinton, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the modulation of chemokine receptor activity. With a total of 2 patents to his name, Zhang's work is recognized for its potential impact on therapeutic applications.
Latest Patents
Zhang's latest patents include innovative compounds that target chemokine receptors. The first patent, titled "Spirohydantoin compounds and methods for the modulation of chemokine receptor activity," focuses on compounds of formula I, which are useful for modulating CCR5 chemokine receptor activity. The second patent, "Spiro compounds and methods for the modulation of chemokine receptor activity," also addresses compounds of formula I, emphasizing their role in the modulation of CCR5 chemokine receptor activity.
Career Highlights
Ming-Qiang Zhang is currently associated with Viro Chem Pharma, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges through novel chemical compounds.
Collaborations
Zhang collaborates with esteemed colleagues, including Laval Chan Chun Kong and Christophe Moinet, to enhance the scope and impact of his research. These collaborations foster a dynamic environment for innovation and discovery.
Conclusion
Ming-Qiang Zhang's contributions to the field of pharmaceutical chemistry are noteworthy, particularly in the area of chemokine receptor modulation. His patents reflect a dedication to advancing medical science and improving therapeutic options.